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Abstract
Background: Very little of the increased attention towards chronic diseases in countries with low and middle incomes 
has been directed towards older people, who contribute 72% of all deaths, and 14% of all Disability Adjusted Life Years 
linked to this group of conditions in those regions. We aimed to study the prevalence of physical, mental and cognitive 
diseases and impairments among older people in the Dominican Republic, their social patterning, and their relative 
contributions to disability.
Methods: A cross-sectional catchment area one-phase survey of chronic disease diagnoses, physical impairments, risk 
factors and associated disability among 2011 people aged 65 years and over (of whom 1451 gave fasting blood 
samples) in Santo Domingo, Dominican Republic.
Results: The most prevalent diagnoses were hypertension (73.0%), anaemia (35.0%), diabetes (17.5%), depression 
(13.8%) and dementia (11.7%), with 39.6% meeting criteria for metabolic syndrome. After direct standardization (for 
age and sex) the prevalences of stroke (standardized morbidity ratio [SMR] 100) and hypertension (SMR 108) were 
similar to those in the United States of America National Health and Nutrition Examination Survey (NHANES reference 
SMR 100), while those of diabetes (SMR 83) and metabolic syndrome (SMR 72) were somewhat lower. Anaemia was 
three times more common than in the USA (SMR 310). Diabetes, hypertension, dyslipidaemia, obesity and the 
metabolic syndrome were associated with affluence and female sex. Arthritis, anaemia, dementia and stroke were 
strongly age-associated and these conditions were also the main independent contributors to disability.
Conclusions: The prevalence of many chronic diseases is similar in predominately low socioeconomic status 
neighbourhoods in the Dominican Republic to that in the USA. Prevalence of age-associated conditions is likely to 
increase with demographic ageing. There is also scope for increases in cardiovascular disease prevalence, if, as 
observed in other settings undergoing the epidemiologic transition, the burden of risk factors shifts towards the less 
affluent. Monitoring future trends in the prevalence and social patterning of chronic diseases may help to assess the 
effectiveness and equity of primary and secondary prevention strategies. Specific recommendations from our research 
include identifying and targeting the causes of anaemia among older people, and addressing women's health 
disadvantages.
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Background
With demographic ageing and the accompanying health
transition, chronic diseases are assuming progressively
greater significance in countries with low and middle
incomes. They are already the leading cause of death in
all world regions apart from sub-Saharan Africa. Of the
35 million chronic disease deaths in 2005, 80% occurred
in countries with low or middle incomes [1], partly
beca us e  m os t  o f  t h e  w o r l d ' s  o l d e r  peo p l e  l i v e  i n  t h e se
regions - 60% now rising to 80% by 2050. However,
changing patterns of risk exposure also contribute. Latin
America exemplifies the third stage of health transition.
As life expectancy improves, and high fat diets, cigarette
smoking and sedentary lifestyles become more common,
so cardiovascular diseases have maximum public health
salience - more so than in stage two regions (China and
India) where risk exposure is not yet so elevated, and in
stage four regions (Europe) where public health measures
have reduced exposure levels [2]. The INTERHEART
cross-national case-control study suggests that risk fac-
tors for myocardial infarction operate equivalently in all
world regions, including Latin America [3].
In a bibliometric analysis of low and middle income
country journals covering the period 1998-2003 more
than 40% of articles focused on chronic disease research,
cardiovascular diseases and cancers being the most popu-
lar topics [4]. However, the Latin American region was
underrepresented. Chronic disability and its determi-
nants have received comparatively little attention, in
research, policy or practice. While cardiovascular dis-
eases and cancers contribute mainly to mortality, much of
the burden of other chronic diseases (dementia, mental
disorders, diabetes and stroke) arises from years lived
with disability [5]. Despite the growing interest in chronic
diseases in low and middle income countries [6,7], there
is limited information available on their prevalence and
impact, and most comprehensive studies focus exclu-
sively or mainly upon young and middle-aged adults [8-
10]. Older people contribute 72% of all deaths [5], and
14% of all years lived with disability linked to chronic dis-
eases in low and middle income countries.
Health policy should be informed by precise estimates
of disease prevalence and burden. These are lacking for
most chronic diseases in most countries with low and
middle incomes, particularly for older adults. The 10/66
Dementia Research Group studies in seven Latin Ameri-
can countries, India and China aim to chart the progress
of the health transition and its impact upon older persons
[11]. This report, from the Dominican Republic, is a com-
prehensive population-based study of the prevalence and
social patterning of chronic disease diagnoses, risk fac-
tors and impairments among older people, and their con-
tribution to disability.
Methods
Setting
The Dominican Republic shares the Caribbean island of
Hispaniola with Haiti. The population is 9.4 million, and
0.5 million (5.7%) are aged 65 and over [12]. Life expec-
tancy is 71 years for men and 75 for women. It is one of
the poorest and most unequal of Latin American coun-
tries. The per capita GDP (purchasing power parity) is
US$ 9,200; 42% of the population live below the poverty
line, one third of whom in extreme poverty. Pension cov-
erage, at only 18% of the economically active population,
is one of the lowest in Latin America. Community health
care is provided by the government through 'primary
attention units'. Consultations are free, but medicines
must be paid for. Despite low medical insurance coverage,
private healthcare is widely patronised.
Study design and catchment area
A one-phase cross-sectional whole population catchment
area survey of all those aged 65 years and over in geo-
graphically defined districts in Santo Domingo. Ethical
approval for the survey was provided by the research eth-
ics committee for the Institute of Psychiatry, King's Col-
lege London, and the Bioethics National Committee for
Research in the Dominican Republic. Precision calcula-
tions indicated that a sample of 2,000 would allow estima-
tion of a dementia prevalence of 2.5% with a precision of
± 0.9%. Catchment area sites were selected purposively,
middle-class or high-income areas were avoided. The
catchment areas selected were Villa Francisca, San Car-
los, San Antón, Mejoramiento Social and Santa Barbara.
After defining boundaries, mapping was carried out to
identify and locate households. All eligible participants
(inclusion criterion age 65 and over) were identified and
invited to participate. Age was formally determined on
revisit for the interview. Participants were recruited fol-
lowing informed consent or on the basis of a relative's
agreement in case of lack of capacity for consent due to
dementia. Interviews were carried out in participants'
own homes. All participants received the full assessment
lasting approximately two to three hours. Ethical
approval for the survey was provided by the King's Col-
lege London research ethics committee, and the Bioethics
National Committee for Research in the Dominican
Republic.
Measures
The components of the 10/66 Dementia Research Group
baseline population-based survey protocol [11,13] that
are relevant to this paper are:
1) a structured clinical mental state interview, the Geri-
atric Mental State, which applies a computer algorithm
(Automated Geriatric Examination for Computer
Assisted Taxonomy - AGECAT) [14], identifying organic-Acosta et al. BMC Public Health 2010, 10:344
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ity (probable dementia), depression, anxiety and psycho-
sis
2) a cognitive test battery comprising the Community
Screening Instrument for Dementia (CSI'D') COG-
SCORE [15] incorporating the Consortium to Establish a
Registry for Alzheimer's Disease (CERAD) animal nam-
ing verbal fluency task, and the modified CERAD 10
word list learning task with delayed recall [16]
3) The CSI'D' informant interview [15], for evidence of
cognitive and functional decline
4) a participant health and risk factor interview cover-
ing self-reported diagnoses (including diabetes, stroke,
heart attack, angina and hypertension), impairments and
disability
5) a fasting blood sample analysed for lipids, glucose
and haemoglobin (Sysmex K800 hematology autoanaly-
ser)
6) a physical examination, including systolic and dia-
stolic blood pressure (the mean of two sitting assess-
ments) and anthropometry
Information from these assessments was used to iden-
tify describe health states (diagnoses, impairments and
risk factors), as follows:
Diagnoses
a) Dementia according to either the 10/66 dementia diag-
nosis algorithm [17] or Diagnostic and Statistical Manual
of Mental Disorders, 4th. Edition (DSM-IV) dementia
criterion [18].
b) Depression - International Classification of Diseases
10th revision (ICD-10) depressive episode (mild, moder-
ate or severe), ascertained using the Geriatric Mental
State [14].
c) Self-reported stroke, angina and myocardial infarc-
tion (an answer of 'yes' to the questions "have you ever
been told by a doctor that you had a stroke/heart attack/
angina?")
d) Chronic obstructive pulmonary disease, defined as
having a chronic cough, productive of sputum for three
or more months
e) Diabetes - either a self-reported diagnosis of diabetes
(an answer of 'yes' to the question "have you ever been
told by a doctor that you have diabetes?"), and/or a blood
glucose of > 7 mmol/l from the survey fasting blood sam-
ple
f) Hypertension - either a self-reported diagnosis of
hypertension, currently under treatment (an answer of
"yes" to the question "have you ever been told that you
have raised blood pressure?" and "yes" to the questions
"were you started on treatment?" and "are you still on
treatment?") and/or meeting World Health Organization/
International Society of Hypertension criteria (systolic
blood pressure > = 140 mm Hg and/or diastolic blood
pressure > = 90 mm Hg on current survey examination.
g) Anaemia - defined as haemoglobin < 12 g/dl for
women and 13 g/dl for men
Physical impairments
Self-reported arthritis or rheumatism; eyesight problems;
hearing difficulty or deafness; persistent cough; breath-
lessness, difficulty breathing or asthma; high blood pres-
sure; heart trouble or angina; stomach or intestine
problems; faints or blackouts; paralysis, weakness or loss
of one leg or arm; skin disorders (pressure sores, leg
ulcers or burns) [19]. Each impairment was rated as pres-
ent if it interfered with activities 'a little' or 'a lot'.
Disability
Activity limitation and participation restriction measured
by the World Health Organization Disability Assessment
Schedule (WHODAS 2.0) [20], developed as a culture-
fair assessment tool for use in cross-cultural comparative
epidemiological and health services research. Disability
days were also ascertained and dichotomised at 15 or
more days in the last month, to indicate severe disability.
Risk factors
a) Metabolic syndrome according to the criteria proposed
by the Third Report of the National Cholesterol Educa-
tion Program: presence of three or more of the following;
1. Central obesity as measured by waist circumference:
Men > 40 inches, Women > 35 inches.
2. Fasting triglycerides > = 150 mg/dL.
3. HDL cholesterol: Men < 40 mg/dL, Women < 50 mg/
dL (Cholesterol subfractions were not analysed, so we
have instead substituted the criterion of total cholesterol
> = 5.2 mmol)
4. Blood pressure > = 130/85 mmHg.
5. Fasting glucose > = 110 mg/dL
b) alcohol use (hazardous drinking currently, and
before the age of 60),
c) lifetime smoking - 20 or more pack years of lifetime
exposure
d) self-reported exercise - taking no walks of 500
metres or more in the past month
Analyses
1) We report the prevalence of each health state by age
and sex using Stata 9.2 survey commands to generate
robust standard errors and 95% confidence intervals, tak-
ing account of household clustering. We used indirect
standardization (by age, or sex, or age and sex as feasible)
to compare our prevalence estimates for diabetes, hyper-
tension, metabolic syndrome, stroke and anaemia with
those from the United States National Health and Nutri-
tion Examination Survey (NHANES) [21-25], and for
dementia with those from the EURODEM consortium
European meta-analysis [26], calculating standardized
morbidity ratios with 95% confidence intervalsAcosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
Page 4 of 17
2) We describe the association between age in years and
each health state, controlling for sex, and the association
with sex controlling for age in years. We also report the
association between socioeconomic position indicated by
quarters of household assets controlling for age in years
and sex. For these analyses we used Poisson regression
working models to generate prevalence ratios, adjusted
for household clustering.
3) We describe independent associations between diag-
noses and impairments and disability using zero inflated
binomial regression for the WHODAS total score (cor-
recting for zero inflation and overdispersion) and Poisson
regression for the dichotomous outcome of 15 or more
disability days in the last month. The resulting prevalence
ratios, together with the prevalence of the exposures
(diagnoses and impairments were used to calculate popu-
lation attributable prevalence fractions using the STATA
aflogit command, as an index of the salience of each
health condition to the prevalence of severe disability at
the population level.
Results
Sample characteristics
Door-knocking of the five catchment areas yielded 2117
persons eligible for the study; 2011 (95%) provided
informed consent and were interviewed. Of these 1483
(74%) provided fasting blood samples. The principal
characteristics of the participants are provided in Table 1.
Their median age was 74 years (interquartile range 69 to
80 years, total range 65 to 104 years). Two thirds of the
participants were female (65.9%). The large majority
(71.0%) had not completed primary education. Living
alone was unusual (12.6%); most lived in two to four per-
son households. A high proportion of participants were
separated or divorced (23.1%), with only 29.1% currently
married. Those providing blood samples were more likely
to be female (68% vs. 60%), depressed (15% vs. 11%), there
were no differences in age, education, household assets,
blood pressure levels or dementia diagnoses.
Prevalence of diagnoses and impairments
The most prevalent chronic disease diagnoses were
hypertension (73.0%), anaemia (35.0%), diabetes (17.5%),
depression (13.8%) and dementia (11.7%). Cardiovascular
diseases; stroke (8.7%), myocardial infarction (1.7%) and
angina (1.2%) were less common (Table 2). The most
prevalent organ and system impairments were eyesight
problems (39.6%), arthritis or rheumatism (36.7%), stom-
ach or intestine problems (19.3%) and hearing problems
(12.7%). Respiratory problems, heart trouble, limb prob-
lems, faints or blackouts and skin disorders all had a prev-
alence of 10% or less (Table 3). Standardizing for age and
sex, the prevalence of anaemia was more than three times
higher than that in the United States of America, (Table
4). Dementia and stroke prevalences were similar to those
r e c o r d e d  i n  E u r o p e  a n d  t h e  U n i t e d  S t a t e s  o f  A m e r i c a
respectively. The prevalence of diabetes and metabolic
syndrome were somewhat lower , and that of hyperten-
sion slightly higher than in the United States of America.
The effects of age and sex
Controlling for sex, the prevalence of dementia, stroke,
anaemia and depression increased with age, while that of
diabetes was lower among older participants (Table 5).
Among the impairments, the prevalence of eyesight and
hearing problems, cough, limb problems and skin disor-
ders all increased with age, as did overall disability (Table
6). Regarding risk factors, the prevalence of dyslipidae-
mia, metabolic syndrome and smoking declined with
increasing age (Tables 7 and 8). Inactivity increased with
age. Controlling for age, stroke and anaemia were more
common in men, while hypertension and depression
were more common in women (Table 5). Most impair-
ments; arthritis, eyesight problems, stomach or intestine
problems, faints or blackouts were more common in
women, who were also more likely to report 15 or more
disability days (Table 6). Most cardiovascular risk factors;
dyslipidaemia, obesity, hyperglycaemia, inactivity, and
the metabolic syndrome were also more common among
women (Table 8). Smoking, however, was considerably
more common among men.
The effect of socioeconomic position
Controlling for age and sex, dementia, chronic obstruc-
tive pulmonary disease, anaemia and depression were
each less prevalent with increasing household assets
(Table 5). The association was in the opposite direction
for diabetes, hypertension, dyslipidaemia, obesity, hyper-
glycaemia and the metabolic syndrome (Tables 5 and 8).
There was a trend for all physical impairments to be
inversely associated with assets, statistically significant
for eyesight problems, cough, breathing difficulties, faints
or blackouts and skin disorders (Table 6). Disability was
also strongly inversely associated with assets. We also
tested for associations with level of education (detailed
results available on request). None of the health condi-
tions positively associated with assets (diabetes, hyper-
tension, dyslipidaemia, obesity, hyperglycaemia and the
metabolic syndrome) was associated with higher levels of
education. However, most of the conditions negatively
associated with household assets were also negatively
associated with level of education (dementia, anaemia
and depression). There were only non-significant trends
towards negative associations between educational level
and individual impairments, but there was a significant
inverse association with disability.Acosta et al. BMC Public Health 2010, 10:344
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Table 1: Sociodemographic and (selected) health characteristics of the sample, and the sub-groups for whom blood 
samples were, and were not taken
Characteristics (number and % unless 
otherwise stated)
Whole sample
(n = 2011)
Blood sample taken 
(n = 1451)
Blood sample not taken 
(n = 560)
Statistical test comparing 
sub-groups with and 
without blood samples
Age median (25th and 75th centiles) 74 (69-80) 74 (69-81) 74 (69-80) Z = -1.46, p = 0.14
Female sex 1324 (65.9%) 316 (60.0%) 1008 (68.0%) X2 = 11.2, p = 0.001
Education (MV1 = 19)
None 392 (19.7%) 98 (18.8%) 294 (20.0%) X2 = 0.8, p = 0.39
Some 1022 (51.3%) 268 (51.5%) 754 (51.2%)
Completed primary 370 (18.6%) 97 (18.7%) 273 (18.5%)
Secondary or tertiary 208 (10.5%) 57 (11.0%) 151 (10.3%)
Living alone 254 (12.6%) 79 (15.0%) 175 (11.8%) X2 = 3.5, p = 0.06
Marital status (MV = 15)
Never married 139 (7.0%) 44 (8.4%) 95 (6.5%) X2 = 4.8, p = 0.19, 3 df
Divorced/separated 465 (23.1%) 133 (25.4%) 332 (22.6%)
Widowed 806 (40.4%) 198 (37.8%) 608 (41.3%)
Currently married 586 (29.1%) 149 (28.45) 437 (29.7%)
Assets
0-4 648 (32.2) 167 (31.6%) 481 (32.4%) X2 = 0.3, p = 0.58
5 444 (22.1) 115 (21.8%) 329 (22.2%)
6 733 (36.4) 194 (36.7%) 539 (36.3%)
7 186 (9.2%) 52 (9.8%) 134 (9.0%)
Three or more limiting illnesses (MV = 2) 465 (23.1%) 115 (21.8%) 350 (23.6%) X2 = 0.7, p = 0.40
Depression 278 (13.8%) 56 (10.6%) 222 (15.0%) X2 = 6.2, p = 0.01
Dementia 235 (11.7%) 68 (12.9%) 167 (11.3%) X2 = 1.0, p = 0.32
Systolic blood pressure mean (SD) (MV = 20) 136.2 (20.1) 136.3 (20.6) 136.2 (20.0) F = 0.56, p = 0.97, 1989
Waist circumference mean (SD)(MV = 25) 92.3 (12.9) 91.6 (13.6) 92.5 (12.6) F = 0.53, p = 0.18, 1984
1. MV = missing valuesAcosta et al. BMC Public Health 2010, 10:344
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Associations with disability
In order of level of contribution, defined by the popula-
tion attributable prevalence fraction, the strongest inde-
pendent influences upon disability were arthritis,
anaemia, limb impairments, dementia, depression, intes-
tinal problems and stroke (Table 9). None of the indica-
tors of ischaemic heart disease or respiratory impairment
was significantly associated with disability.
Discussion
In the current study we were able to ascertain the preva-
lence and distribution of a wide range of chronic disease
diagnoses, impairments and underlying risk factors in a
large population-based sample drawn from urban catch-
ment areas in Santo Domingo, the capital city of the
Dominican Republic. There have been very few previous
reports of the prevalence of chronic diseases and their
risk factors among older people, in countries with low
and middle incomes in Latin America or other regions. In
our study, the catchment areas were selected as typical
examples of the lower income areas that account for
much of Santo Domingo's population. However, findings
from this survey cannot be generalised safely to other
parts of the city or to the country as a whole. Not all diag-
noses were ascertained with equivalent rigour; self-
reported clinician diagnoses, for example stroke and
heart disease, may have been under-reported with
respect to other conditions such as dementia and depres-
sion that were identified through clinical interview, and
hypertension and diabetes that were identified through
blood pressure and fasting glucose measurement respec-
tively. The overall proportion responding, 95%, was very
high. However, only 74% of those agreeing to the survey
also supplied fasting blood samples that were used to
identify diabetes, hyperlipidaemia, metabolic syndrome
and anaemia. While most sociodemographic and health
variables were not associated with provision of a blood
sample, women, depressed participants, and those with
three or more limiting impairments were slightly over-
represented among those giving blood samples suggest-
ing some potential for non-response bias in the estima-
tion of the prevalence and correlates of these metabolic
and haematological disorders.
In the CARMELA study of cardiovascular risk in those
aged 25-64 years in seven Latin American cities [8], the
prevalences of hypertension, diabetes and metabolic syn-
drome were similar to developed countries in Venezuela,
Argentina and Chile with a lower prevalence in the less
developed Latin American countries. The Dominican
Republic is just 90 minutes flying time from Miami but
purchasing power parity per capita gross domestic prod-
uct is only one fifth that of the United States of America
($9,200 versus $46,000). Demographic ageing is much
less advanced in the Dominican Republic, with just 5.7%
of its population aged 65 and over, compared with 12.6%
in the United States of America. Nevertheless, the age
and sex adjusted prevalence of dementia and stroke seem
already to have reached levels seen in Europe and the
United States of America. Hypertension is, if anything,
slightly more prevalent in the Dominican Republic. The
high prevalence of hypertension and stroke may be
explained in part by the high levels of African racial
admixture seen in many residents of our catchment areas.
Only diabetes and the metabolic syndrome were margin-
ally less prevalent than in the United States of America.
At the same time, anaemia, a condition strongly linked to
dietary deficiency and poverty is more than three times
more common in the Dominican Republic. This pattern
of morbidity illustrates the 'double burden' of disease in
countries undergoing the health transition - as chronic
diseases become more prevalent, infectious and nutri-
tional disorders recede but continue to make important
contributions to mortality and disability.
Predicting the impact of the demographic and health
transitions requires an understanding of the influences of
age, sex and socioeconomic status on disease frequency
and underlying risk factor exposures. In the Dominican
Republic the negative relationship with increasing age for
all cardiovascular risk factors other than hypertension
suggests either a cohort effect with increasing exposure
levels to be anticipated in future aged cohorts, or selec-
tive mortality, in which case improved secondary preven-
tion may lead over time to more chronic morbidity and
disability. Most of the disorders that were positively asso-
ciated with older age (arthritis, anaemia, dementia,
stroke, limb impairments) also made strong independent
contributions to disability. Thus, in this setting, the num-
bers of frail and dependent older persons are likely to
increase rapidly with demographic ageing. We have pre-
viously shown that the age-specific prevalence of depen-
dence in the Dominican Republic is already similar to
that in developed nations [27]. Unfortunately, social pro-
tection for older people in the Dominican Republic is
very poorly developed. Pension coverage has been among
the poorest in the world. Our survey indicated a particu-
larly high proportion of older people without children
available to care [28], both because of infertility and out-
migration.
In the United States of America, the age-adjusted prev-
alence of hypertension [29], diabetes [21] and the meta-
bolic syndrome [22] is similar in men and women.
However, women with diabetes and hypertension may be
at greater risk of cardiovascular disease [30]. The preva-
lence of metabolic syndrome in the Dominican Republic
was double in older women that of men, mainly due to a
marked excess of obesity and dyslipidaemia among
women, and a trend towards a higher prevalence of dia-
betes. This is consistent with findings among youngerAcosta et al. BMC Public Health 2010, 10:344
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Latin Americans [8], but contrasts with the higher preva-
lence among men in many developed country studies,
albeit that recent increases in prevalence have been more
rapid among younger women [30]. In our study, older
women were also more likely to have been diagnosed as
hypertensive, but were generally better controlled.
Despite the generally increased cardiovascular risk expo-
sure among women, the prevalence of stroke was mark-
edly higher among men in all age groups and there was
little effect of sex on ischemic heart disease. The very low
levels of smoking among women may have compensated.
Our most striking findings relate to health inequalities.
In countries with high incomes, cardiovascular risk fac-
tors and diseases are typically associated with poverty.
Our assessment of the effects of the effects of socioeco-
nomic position on chronic disease outcomes may have
been limited to some extent by the constrained variance
in the predominately low social class catchment areas.
Table 2: Prevalence of Diagnoses by Age and Sex
Prevalence of diagnoses by age and sex (% with 95% confidence intervals)
Diagnoses Sex 65-69
N = 533
70-74
N = 520
75-79
N = 397
80+
N = 561
All
N = 2011
Dementia
(10/66 criterion)
F3 . 5
1.6, 5.4
7.1
4.3, 9.9
11.7
7.8, 15.5
25.5
21.2, 29.8
12.5
10.8, 14.3
M4 . 8
1.7, 7.8
6.1
2.8, 9.5
14.5
8.5, 20.5
17.2
11.5, 22.9
10.1
7.8, 12.3
Stroke F 4.7
2.4, 6.9
9.0
5.9, 12.1
5.3
2.6, 7.9
10.7
7.7, 13.8
7.6
6.2, 9.1
MV1 = 6 M9 . 0
4.9, 13.1
13.8
8.9, 18.6
7.6
3.1, 12.2
11.9
7.0, 16.8
10.8
8.5, 13.2
Myocardial infarction F 1.7
0.4, 3.1
2.2
0.6, 3.8
2.3
0, 5, 4.0
1.5
0.3, 2.7
1.9
1.2, 2.6
MV = 35 M 1.6
0.0, 3.4
1.5
0.0, 3.3
1.5
0.0, 3.6
1.2
0.0, 2.8
1.5
0.6, 2.4
Angina F 1.2
0.0, 2.3
2.2
0.6, 3.8
0.4
0.0, 1.1
1.3
0.2, 2.4
1.3
0.7, 1.9
MV = 25 M 1.1
0.0, 2.5
0.5
0.0, 1.5
1.5
0.0, 3.6
1.8
0.0, 3.8
1.2
0.4, 2.0
Chronic obstructive pulmonary disease F 6.1
3.6, 8.7
7.1
4.3, 9.9
6.0
3.2, 8.9
5.6
3.3, 7.9
6.2
4.9, 7.5
MV = 3 M 6.4
2.9, 9.9
6.6
3.1, 10.1
9.9
4.8, 15.0
10.1
5.6, 14.7
8.1
6.0, 10.1
Hypertension (meets ISH criteria, and/or currently on 
treatment)
F7 1 . 0
66.2, 75.8
76.4
71.8, 81.0
75.2
70.0, 80.3
77.6
73.4, 81.8
75.1
72.7, 77.5
MV = 13 M 67.7
61.1, 74.4
72.2
65.9, 78.5
68.2
60.2, 76.3
67.3
60.1, 74.5
69.0
65.5, 72.5
Diabetes (self-reported diagnosis and/or blood glucose 
of > 7 mmol/l)
F2 0 . 5
15.7, 25.4
22.2
17.0, 27.3
15.3
10.3, 20.2
15.6
11.4, 19.8
18.4
16.0, 20.9
M2 0 . 5
13.6, 27.3
16.5
10.2, 22.9
14.4
7.2, 21.7
10.1
4.7, 15.5
15.6
12.3, 18.9
Anaemia F 30.7
25.1, 36.2
25.5
20.0, 31.0
38.8
32.1, 45.6
39.0
33.4, 44.6
33.4
30.5, 36.3
MV = 10 M 28.8
21.1, 36.5
31.8
23.9, 39.8
40.0
29.9, 50.1
54.6
45.7, 63.6
38.3
33.8, 42.7
ICD-10 depression F 14.0
10.3, 17.7
13.9
10.1, 17.8
16.2
11.7, 20.6
16.8
13.1, 20.5
15.3
13.2, 17.2
M8 . 5
4.5, 12.4
6.6
3.1, 10.1
16.0
9.7, 22.3
15.4
9.9, 20.8
11.1
8.7, 13.4
1. MV = missing valuesAcosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
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Table 3: Prevalence of Impairments and Disability by Age and Sex
Impairments and disability Prevalence of impairments by age and sex (% with 95% confidence intervals)
Sex 65-69
N = 533
70-74
N = 520
75-79
N = 397
80+
N = 561
All
N = 2011
Arthritis or rheumatism F 42.6
37.3, 47.8
42.7
37.3, 48.1
47.4
41.4, 53.4
44.6
39.8, 49.5
44.2
41.5, 46.9
MV1 = 3 M2 0 . 7
14.9, 26.5
19.9
14.3, 25.5
22.9
15.7, 30.1
25.6
18.9, 32.3
22.1
19.0, 25.2
Eyesight problems F 38.5
33.3, 43.6
37.2
31.8, 42.5
39.6
33.7, 45.5
49.2
44.3, 54.2
41.6
38.9, 44.2
MV = 3 M 30.7
24.1, 37.3
31.1
24.6, 37.6
36.6
28.4, 44.9
46.4
38.9, 53.9
35.8
32.2, 39.4
Hearing difficulty or deafness F 8.5
5.5, 11.4
8.7
5.6, 11.7
11.3
7.5, 15.1
19.1
15.3, 23.0
12.2
10.5, 14.0
MV = 3 M 8.5
4.5, 12.4
11.7
7.2, 16.2
11.5
6.0, 17.0
23.2
16.8, 29.6
13.6
11.0, 16.2
Persistent cough F 8.5
5.5, 11.4
10.8
7.4, 14.2
10.5
6.8, 14.2
12.2
9.0, 15.4
10.6
8.9, 12.2
MV = 3 M 10.6
6.2, 1.5
7.1
3.5, 10.8
9.2
4.2, 14.1
12.6
15.5, 17.6
9.9
7.6, 12.0
Difficulty breathing, breathlessness or 
asthma
F8 . 7
5.8, 11.7
9.3
6.1, 12.4
9.8
6.2, 13.3
12.0
8.8, 15.2
10.0
8.4, 11.7
MV = 2 M 10.1
5.8, 14.3
7.1
3.5, 10.8
6.9
2.5, 11.2
9.5
5.1, 13.9
8.5
6.4, 10.6
Heart trouble or angina F 5.0
2.7, 7.3
5.9
3.3, 8.5
3.4
1.2, 5.6
4.8
2.7, 7.0
4.8
3.7, 6.0
MV = 3 M 2.6
0.4, 4.9
4.1
1.3, 6.9
6.9
2.5, 11.2
4.2
1.1, 7.2
4.2
2.7, 5.8
Stomach or intestine problems F 19.5
15.3, 23.7
22.3
17.7, 26.9
21.9
16.9, 26.9
23.0
18.8, 27.2
21.7
19.5, 23.9
MV = 4 M 12.7
7.9, 17.5
16.8
11.6, 22.1
13.7
7.8, 19.6
14.9
9.3, 20.4
14.6
12.0, 17.3
Faints or blackouts F 3.5
1.6, 5.4
2.8
1.0, 4.6
3.8
1.5, 6.0
5.9
3.6, 8.2
4.1
3.0, 5.2
MV = 5 M 2.6
0.4, 4.9
2.6
0.3, 4.8
1.5
0.0, 3.6
3.0
0.4, 5.6
2.5
1.3, 3.7
Paralysis, weakness or loss of one leg or 
arm
F3 . 2
1.3, 5.1
3.7
1.7, 5.8
1.9
0.2, 3.5
10.1
7.1, 13.0
5.1
3.9, 6.3
MV = 7 M 2.7
0.4, 5.0
6.6
3.1, 10.1
5.3
1.5, 9.2
6.0
2.4, 9.5
5.1
3.5, 6.8
Skin disorders pressure sores, leg ulcers or 
burns
F1 . 7
0.4, 3.1
0.6
0.0, 1.5
1.9
0.2, 3.5
4.3
2.3, 6.4
2.3
1.5, 3.1
MV = 6 M 1.1
0.0, 2.5
0.5
0.0, 1.5
0.8
0.0, 2.3
3.0
0.4, 5.5
1.3
0.5, 2.2
More than 15 disability days in the last 
month
F1 0 . 5
7.2, 13.7
11.8
8.3, 15.3
14.7
10.4, 18.9
28.5
24.0, 33.0
16.9
14.9, 19.0
MV = 5 M 9.0
4.9, 13.1
13.2
8.5, 18.0
11.5
6.0, 17.0
17.2
11.5, 23.0
12.7
10.2, 15.2
1. MV = missing values (men and women combined)A
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Table 4: Comparison of Prevalence of Health Conditions Between Dominican Republic and Developed Country Settings, With Indirect Standardisation for Age and 
Sex
Health condition Criterion Prevalence (%) in 
Dominican Republic 
sample
Source of comparison 
prevalence data
Standardised for Standardised morbidity 
ratio
95% confidence
 intervals
Diagnosed diabetes Told by a doctor that he/she has 
diabetes
14.0% NHANES 1999-2002, USA 
[21]
Sex, among those aged 
65 and over
88 73, 107
Undiagnosed diabetes Never told by doctor that he/she 
has diabetes, and fasting glucose 
> = 7 mmol/l
3.5% NHANES 1999-2002, USA 
[21]
Sex, among those aged 
65 and over
65 45, 92
Diabetes Diagnosed or undiagnosed 
diabetes
17.5% NHANES 1999-2002, USA 
[21]
Sex, among those aged 
65 and over
83 70, 97
Hypertension Blood pressure > = 140/90 or on 
antihypertensive treatment
73.8% NHANES 1999-2004, USA 
[23]
Sex, among those aged 
60 and over
108 101, 117
Age (60-69,70-79, 80+) 105 98, 113
Metabolic syndrome NCEP - ATP III criteria, but those 
diagnosed with diabetes 
considered dysglycaemic and 
those told they were hypertensive 
considered hypertensive, 
regardless of current control
39.6% NHANES 1999-2002, USA 
[22]
Age (60-69,70+) and sex 72 64, 80
Stroke Told by a doctor that he/she has 
had stroke
8.7% NHANES 1999-2004, USA 
[24]
Age (65-74, 75+) and sex 100 81, 123
Dementia DSM-IV dementia 5.4% EURODEM meta-analysis, 
Europe [26]
Age (five year bands) and 
sex
85 65, 110
Anaemia WHO criteria - haemoglobin < 12 
g/dl in women, < 13 g/dl in men
35.0% NHANES III, 1988-1994, 
USA [25]
Age (65-74, 75-84, 85+) 
and sex
310 262, 373Acosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
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Nevertheless, among older people in the Dominican
Republic this pattern of association was observed, but
only for the more age-related and disabling conditions
(dementia, anaemia, depression and most of the chronic
limiting impairments). Conversely, cardiovascular risk
factors (hypertension, diabetes, dyslipidaemia, obesity
and the metabolic syndrome) were each associated with
relative affluence, and there was no socioeconomic gradi-
ent for ischaemic heart disease or stroke. These findings
are consistent with associations observed in a nationally
representative survey of Thais aged 50 years and older,
where poor self-rated health and functional limitation
were associated with lower levels of education, income
and wealth, but self-reported diagnoses of hypertension
and heart disease were over-represented in the more
affluent [31]. Urbanization may have important influ-
ences on the socioeconomic patterning of health; in the
nationally representative Mexican Health and Ageing
Study activity limitation was consistently associated with
socioeconomic disadvantage in urban but not in rural
areas [32]. In Buenos Aires, in a survey of adults of all
ages, hypertension diagnosis was associated with low
education and income in both sexes, as were obesity and
high body mass index in women but not men [33]. In high
income countries metabolic syndrome tends to be
inversely associated with socioeconomic position in mid-
dle age; few studies have included older persons, but in
the United States of America NHANES the effect of
socioeconomic position was limited to women aged 25-
64 [34]. Little research has been conducted in countries
with low and middle incomes, but our findings are con-
sistent with reports from India of a higher prevalence of
metabolic syndrome among better educated adolescents
[35]. With regard to lifestyle risk factors, much more
research has been conducted into associations between
socioeconomic position and obesity, documenting the
progress of the health transition in countries with low
and middle incomes - obesity is no longer confined to the
Table 5: Effects of Age, Sex and Socioeconomic Position on Diagnoses
Associations with diagnoses (prevalence ratios with 95% confidence intervals)
Diagnoses Age, adjusted for sex Sex, adjusted for age Socioeconomic position (quarters 
of household assets), adjusted for 
age and sex
Dementia
(10/66 criterion)
1.08
1.07, 1.10
p < 0.001
0.89
0.69, 1.15
p = 0.38
0.87
0.77, 0.97
p = 0.02
Stroke
MV1 = 6
1.02
1.00, 1.04
p = 0.01
1.45
1.09, 1.93
p = 0.01
1.01
0.88, 1.16
p = 0.88
Myocardial infarction
MV = 35
1.00
0.96, 1.03
p = 0.84
0.77
0.37, 1.60
p = 0.49
0.92
0.66, 1.27
p = 0.60
Angina
MV = 25
1.02
0.96, 1.07
p = 0.58
0.92
0.39, 2.16
p = 0.86
1.18
0.79, 1.76
p = 0.41
Chronic obstructive pulmonary 
disease 
MV = 3
1.01
0.99, 1.03
p = 0.47
1.31
0.93, 1.84
p = 0.12
0.84
0.72, 0.98
p = 0.02
Hypertension (meets ISH criteria, and/
or currently on treatment) 
MV = 13
1.00
1.00, 1.01
p = 0.15
0.92
0.87, 0.98
p = 0.006
1.04
1.01, 1.07
p = 0.004
Diabetes (self-reported diagnosis and/
or blood glucose of > 7 mmol/l)
0.98
0.96, 0.99
p = 0.005
0.84
0.66, 1.07
p = 0.15
1.13
1.01, 1.26
p = 0.03
Anaemia
MV = 10
1.03
1.02, 1.03
p < 0.001
1.16
1.01, 1.34
p = 0.04
0.85
0.79, 0.91
p < 0.001
ICD-10 depression 1.02
1.01, 1.03
p = 0.003
0.74
0.58, 0.95
p = 0.02
0.70
0.63, 0.78
p = < 0.001
1. MV = missing valuesAcosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
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more affluent and inverse associations with socioeco-
nomic position are increasingly observed, particularly for
women living in countries with per capita GDP greater
than $2500 [36]. In Brazil, for example, there was a clear
shift in the burden of obesity towards the poor between
1975 and 2003; the prevalence in women remained stable
overall, but increased by 26% in the poorest two-fifths
and decreased by 10% among the richest three-fifths [37].
The health transition is therefore likely to accentuate
health inequalities. In the United States of America,
reductions over the last 30 years in hypertension and dys-
lipidaemia have not lessened socioeconomic differences,
and those for smoking and diabetes have increased due to
less smoking in high income groups and increases in dia-
betes prevalence among those with low incomes [38]. The
effect of the health transition on health inequalities may
be particularly marked among older people. In the longi-
tudinal American's Changing Lives Study [39], socioeco-
nomic differences in health are modest in youth, increase
markedly across middle age into young old age, and
decline thereafter, a pattern observed consistently in
developed country studies. There is evidence from the
American's Changing Lives study that compression of
morbidity (the increasing tendency for the preservation
Table 6: Effects of Age, Sex and Socioeconomic Position on Impairments and Disability
Impairments and disability Associations with impairments and disability (prevalence ratios with 95% confidence 
intervals)
Age, adjusted for sex Sex, adjusted for age Socioeconomic position (quarters 
of household assets), adjusted for 
age and sex
Arthritis or rheumatism
MV1 = 3
1.00
1.00, 1.01
p = 0.23
0.50
0.43, 0.59
p < 0.001
0.98
0.92, 1.04
p = 0.47
Eyesight problems
MV = 3
1.02
1.01, 1.02
p < 0.001
0.88
0.78, 0.98
p = 0.02
0.90
0.85, 0.95
p < 0.001
Hearing difficulty or deafness
MV = 3
1.06
1.04, 1.07
p < 0.001
1.19
0.94, 1.49
p = 0.15
0.91
0.81, 1.02
p = 0.10
Persistent cough
MV = 3
1.02
1.00, 1.04
p = 0.02
0.95
0.72, 1.24
p = 0.69
0.86
0.76, 0.98
p = 0.02
Difficulty breathing, breathlessness or 
asthma
MV = 2
1.01
0.99, 1.03
p = 0.26
0.85
0.64, 1.14
p = 0.28
0.75
0.66, 0.86
p < 0.001
Heart trouble or angina
MV = 3
1.00
0.98, 1.03
p = 0.98
0.88
0.57, 1.35
p = 0.55
0.81
0.68, 0.97
p = 0.02
Stomach or intestine problems
MV = 4
1.01
1.00, 1.02
p = 0.16
0.68
0.55, 0.83
p < 0.001
0.95
0.87, 1.04
p = 0.28
Faints or blackouts
MV = 5
1.02
0.99, 1.05
p = 0.14
0.62
0.36, 1.06
p = 0.08
0.73
0.57, 0.93
p = 0.01
Paralysis, weakness or loss of one leg 
or arm
MV = 7
1.06
1.03, 1.08
p < 0.001
1.07
0.72, 1.59
p = 0.72
0.86
0.71, 1.03
p = 0.10
Skin disorders pressure sores, leg 
ulcers or burns
MV = 6
1.06
1.02, 1.10
p = 0.001
0.62
0.30, 1.31
p = 0.21
0.58
0.42, 0.81
p = 0.001
More than 15 disability days in the last 
month
MV = 5
1.05
1.04, 1.06
p < 0.001
0.80
0.63, 1.00
p = 0.05
0.89
0.80, 0.99
p = 0.03
1. MV = missing valuesAcosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
Page 12 of 17
Table 7: Prevalence of Risk Factors by Age and Sex
Prevalence of risk factors by age and sex (% with 95% confidence intervals)
Risk factors Sex 65-69
N = 4001
N = 5332
70-74
N = 3821
N = 5202
75-79
N = 2931
N = 3972
80+
N = 4081
N = 5612
All
N = 14831
N = 20112
Metabolic syndrome
(NCEP criteria)
F3 8 . 2
32.3, 44.1
46.3
40.1, 52.6
37.3
30.6, 44.0
35.7
30.1, 41.2
39.3
36.3, 42.4
MV3 = 30 M2 3 . 3
16.0, 30.6
26.2
18.6, 33.7
15.3
7.6, 23.0
15.5
8.9, 22.1
20.7
16.9, 24.4
Metabolic syndrome components
Triglyceride > 150 mg/dl F 24.5
19.3, 29.7
24.5
19.1, 29.9
14.4
9.5, 19.3
19.4
14.8, 24.0
21.0
18.5, 23.6
MV = 31 M 19.4
12.5, 26.2
16.2
9.8, 22.5
18.8
10.5, 27.1
10.3
4.8, 15.9
16.1
12.7, 19.4
Total cholesterol > = 5.2 mmol F 49.4
43.4, 55.5
48.2
41.9, 54.5
47.8
40.8, 54.7
41.0
35.3, 46.7
46.3
43.2, 49.5
MV = 31 M 35.7
27.4, 43.9
36.9
28.6, 45.2
28.2
18.7, 37.8
22.4
14.8, 30.0
31.3
27.0, 35.6
Waist circumference; Men > 40 inches, Women > 35 
inches
F6 2 . 8
57.0, 68.7
64.1
58.0, 70.2
58.2
51.3, 65.0
56.5
50.8, 62.3
60.4
57.4, 63.4
MV = 25 M 19.4
12.5, 26.2
20.0
13.1, 26.9
18.8
10.5, 27.1
23.3
15.6, 31.0
20.4
16.7, 24.1
Blood pressure
> = 130/85 mmHg
F5 9 . 2
53.2, 65.1
69.1
63.3, 74.9
70.1
63.8, 76.5
68.4
63.0, 73.9
66.4
63.5, 69.4
MV = 20 M 71.9
64.1, 79.7
77.7
70.5, 84.9
64.7
54.5, 74.9
67.2
58.7, 75.8
71.0
66.9, 75.2
Fasting glucose
> 110 mg/dl
F2 6 . 0
20.6, 31.3
28.5
22.8, 34.1
30.3
24.0, 36.7
27.0
21.7, 32.1
27.7
24.9, 30.5
MV = 32 M 28.1
20.3, 35.9
27.7
20.0, 35.4
27.1
17.6, 36.5
18.1
11.1, 25.1
25.3
21.3, 29.2
Other risk factors
Limited exercise (no walks of > 0.5 km in last month) F 30.1
25.2, 35.0
36.8
31.5, 42.1
35.6
29.8, 41.4
64.9
60.1, 69.7
43.1
40.4, 45.8
MV = 12 M 17.6
12.1, 23.0
24.5
18.5, 30.5
27.3
19.6, 35.1
35.9
28.7, 43.2
25.9
22.6, 29.2
Smoking
(> 20 pack years)
F1 1 . 0
7.6, 14.4
10.3
6.8, 13.8
11.8
7.8, 15.7
8.3
5.5, 11.1
10.2
8.5, 11.9
MV = 114 M 35.5
28.6, 42.4
33.0
26.3, 39.7
29.2
21.0, 37.3
28.9
21.9, 35.9
32.0
28.4, 35.6
1. Sample size with blood tests
2. Total sample size
3. MV = missing values (men and women combined)Acosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
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of health and functioning into late old age) is mainly
observed in the most educated, and that this effect is
becoming more pronounced over time.
Conclusions
The prevalence of many chronic diseases and chronic dis-
ease risk factors is already nearly as high in low socioeco-
nomic status neighbourhoods in Santo Domingo,
Dominican Republic as in the USA. Cautious extrapola-
tion from our cross-sectional data suggests that the over-
all prevalence of conditions that are strongly age-
associated (dementia, stroke and arthritis) is likely to rise
in coming years with continued demographic ageing.
There is also scope for increases in the prevalence of
those cardiovascular risk factors currently associated
with relative affluence (diabetes, hypertension, dyslipi-
daemia, obesity and the metabolic syndrome), if, as has
been observed in other settings undergoing the epidemi-
ologic transition, these exposures begin to be concen-
trated instead among the more numerous economically
disadvantaged sectors of the population. This scenario
would threaten both an increase in the overall incidence
and prevalence of cardiovascular diseases, and in the
extent of health inequalities. It will be important to moni-
tor the actual extent and direction of such trends with
further epidemiological research, in particular to assess
the effectiveness and equity of attempts to improve the
prevention and control of chronic diseases. The generally
poor health of older women in the Dominican Republic
should be a matter of public health concern, and a focus
for prevention activities. Controlling for age, women
were likelier than men to be hypertensive, dyslipidaemic,
Table 8: Effects of Age, Sex and Socioeconomic Position on Risk Factors
Associations with risk factors (prevalence ratios with 95% confidence intervals)
Risk factors Age, adjusted for sex Sex, adjusted for age Socioeconomic position (quarters of 
household assets), adjusted for age and sex
Metabolic syndrome
(NCEP criteria)
MV1 = 30
0.93
0.88, 1.00
P = 0.04
0.52
0.43, 0.63
P < 0.001
1.17
1.09, 1.25
P < 0.001
Metabolic syndrome components
Triglyceride > 150 mg/dl
MV = 31
0.88
0.81, 0.96
P = 0.009
0.76
0.60, 0.96
P = 0.02
1.22
1.10, 1.35
P < 0.001
Total cholesterol > = 5.2 mmol
MV = 31
0.93
0.88, 0.97
P = 0.002
0.67
0.58, 0.78
P < 0.001
1.09
1.02, 1.16
P = 0.007
Waist circumference; Men > 40 inches, 
Women > 35 inches MV = 25
0.97
0.93, 1.01
P = 0.14
0.33
0.27, 0.40
P < 0.001
1.11
1.06, 1.17
P < 0.001
Blood pressure
> = 130/85 mmHg
MV = 20
1.01
0.98, 1.05
P = 0.35
1.07
0.99, 1.15
P = 0.07
1.01
0.97, 1.04
P = 0.74
Fasting glucose
> 110 mg/dl
MV = 32
0.97
0.90, 1.04
P = 0.49
0.91
0.76, 1.09
P = 0.31
1.14
1.04, 1.24
P = 0.03
Other risk factors
Limited exercise (no walks of > 0.5 km in 
last month)
MV = 12
1.16
1.13, 1.20
P < 0.001
0.78
0.73, 0.83
P < 0.001
1.00
0.97, 1.03
P = 0.96
Smoking
(> 20 pack years)
MV = 114
0.93
0.86, 1.01
P = 0.08
3.10
2.54, 3.78
P < 0.001
0.94
0.86, 1.03
P = 0.20
1. MV = missing valuesA
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Table 9: Independent Associations Between Diagnoses and Impairments, and Disability
Outcome WHODAS II disability score 15 or more disability days
Median score in 
the exposed 
group 
(interquartile 
range)
Independent associations between
diagnoses and impairments and
WHODAS II score 1
Proportion (%) with 
15 or more disability 
days- in the exposed 
group
Independent associations between diagnoses
and impairments and 15 or more disability
days 2
Exposure Number and 
proportion (%) 
exposed
RR 95% confidence 
intervals
PR 95% confidence
 intervals
Population attributable 
prevalence fraction
Diagnoses
Dementia
(10/66 criterion)
235 (11.7%) 27.8 (8.3-58.3) 1.57 1.40, 1.77 79/235 (33.6%) 1.50 1.16, 1.95 10.5%
Stroke 175 (8.7%) 27.8 (8.3-57.6) 1.37 1.21, 1.55 65/175 (37.1%) 1.46 1.12, 1.91 6.5%
Myocardial infarction 35 (1.7%) 19.4 (5.6-38.9) 0.90 0.74, 1.09 7/35 (20.0%) 0.82 0.42, 1.61
Angina 25 (1.2%) 22.2 (1.4-44.4) 1.23 0.88, 1.73 8/25 (32.0%) 1.50 0.87, 2.57 0.8%
Hypertension 1516 (75.4%) 8.3 (0.0-27.8) 1.00 0.90, 1.11 245/1515 (16.2%) 1.06 0.81, 1.38 5.7%
Chronic obstructive pulmonary 
disease
137 (6.8%) 22.2 (5.6-41.7) 1.02 0.90, 1.16 36/137 (26.3%) 1.18 0.85, 1.64 1.6%
Diabetes 3 260 (17.5%) 13.9 (0.0-30.6) 1.07 0.96, 1.19 48/260 (18.5%) 0.92 0.68, 1.26 Inverse association
Anaemia 3 515 (35.0%) 13.9 (0.0-35.4) 1.16 1.06, 1.27 20/84 (23.8%) 1.53 1.16, 2.02 17.1%
ICD-10 depression 278 (13.8%) 33.3 (16.7-50.0) 1.43 1.30, 1.57 91/278 (32.7%) 1.48 1.16, 1.90 9.4%
Impairments
Arthritis or rheumatism 737 (36.7%) 19.4 (5.6-33.3) 1.34 1.23, 1.46 167/736 (22.7%) 1.68 1.35, 2.10 22.5%
Eyesight problems 796 (39.6%) 19.4 (5.6-36.1) 1.13 1.04, 1.23 153/795 (19.2%) 1.01 0.81, 1.27 1.8%
Hearing difficulty or deafness 255 (12.7%) 25.0 (5.6-43.7) 1.17 1.05, 1.30 60/255 (23.5%) 1.10 0.80, 1.72 0.9%
Persistent cough 207 (10.3%) 19.4 (5.6-41.7) 1.01 0.90, 1.13 55/206 (26.7%) 1.11 0.83, 1.47 2.0%
Difficulty breathing, 
breathlessness or asthma
191 (9.5%) 30.6 (11.1-47.2) 1.12 1.00, 1.27 60/190 (31.6%) 1.19 0.88, 1.60 2.8%
Heart trouble or angina 93 (4.6%) 27.8 (11.1-40.9) 1.11 0.96, 1.30 26/93 (28.0%) 1.17 0.79, 1.71 0.9%
Stomach or intestine problems 388 (19.3%) 25.0 (8.3-44.4) 1.27 1.16, 1.39 103/388 (26.5%) 1.33 1.04, 1.71 8.9%A
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Faints or blackouts 71 (3.5%) 33.3 (18.1-56.3) 1.30 1.10,1.53 29/71 (40.8%) 1.25 0.82, 1.92 1.5%
Paralysis, weakness or loss of 
one leg or arm
102 (5.1%) 50.0 (27.8-69.4) 1.88 1.67,2.12 60/102 (58.8%) 2.50 1.92, 3.25 11.8%
Skin disorders (pressure sores, 
leg ulcers or burns)
39 (1.9%) 50.0 (27.8-69.4) 1.70 1.40,2.08 21/39 (53.8%) 2.43 1.57, 3.77 4.3%
1 Zero-inflated negative binomial regression, adjusted for all other diagnoses and impairments other than diabetes and anaemia. N = 1975 (see also footnote 3
2 Poisson regression
3 Parameters for diabetes and anaemia were obtained from a separate model restricted to those participants who had provided a blood sample
Table 9: Independent Associations Between Diagnoses and Impairments, and Disability (Continued)Acosta et al. BMC Public Health 2010, 10:344
http://www.biomedcentral.com/1471-2458/10/344
Page 16 of 17
obese and underactive and had a higher prevalence of the
metabolic syndrome, depression, physical impairments
and severe disability. More research into the prevalence
and causes of anaemia in older people is indicated, and
the government should consider evaluating screening and
treatment programmes. Finally, more attention should be
given to the social protection of older people, including
income security and provision and financing of long term
care [40].
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